By computing the intersection of these machine-learning-predicted core target genes, five of them (TUBB3, JUN, EPHA2, FOS, and CDKN1C) were identified as the target hub genes of CRC treatment with LWMX pills (Figure 4g). This evidence concerns the gene CDKN1C and colorectal carcinoma.